1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Sawai, M.V. Jia, H.P. Liu, L. Aseyev, V. Wiencek, J.M. McCray Jr., P.B. Ganz, T. Kearney, W.R. Tack, B.F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 40 3810 3816 10.1021/bi002519d 11300761 The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. 2001 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4342.271 BETA-DEFENSIN-2 1 man polymer no no GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo fall armyworm sample 9606 Homo sapiens SF21 7108 SPODOPTERA FRUGIPERDA BACULOVIRUS atom_site entity_src_gen pdbx_struct_assembly pdbx_struct_assembly_prop pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Atomic model Data collection Derived calculations Source and taxonomy 1 0 2001-04-11 1 1 2008-04-27 1 2 2011-07-13 2 0 2018-10-24 _atom_site.auth_atom_id _atom_site.label_atom_id _entity_src_gen.host_org_common_name _entity_src_gen.pdbx_host_org_cell_line _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id _entity_src_gen.pdbx_host_org_scientific_name _entity_src_gen.pdbx_host_org_vector_type RCSB Y PDBJ 2000-09-06 REL REL This structure was determined using standard 2D homonuclear techniques. structures with the lowest target function value 100 20 2D NOESY,DOF-COSY,TOCSY 0.045 3.7 1013 hpa 298 K Simulated annealing, torsion angle dynamics 1 lowest energy 0.9mM Human Beta-Defensin-2; 45mM sodium phosphate buffer 90% H2O/10% D2O Guentert structure solution DYANA 1.5 Guentert refinement DYANA 1.5 500 Varian INOVA GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A GLY 3 n 3 GLY 3 A ASP 4 n 4 ASP 4 A PRO 5 n 5 PRO 5 A VAL 6 n 6 VAL 6 A THR 7 n 7 THR 7 A CYS 8 n 8 CYS 8 A LEU 9 n 9 LEU 9 A LYS 10 n 10 LYS 10 A SER 11 n 11 SER 11 A GLY 12 n 12 GLY 12 A ALA 13 n 13 ALA 13 A ILE 14 n 14 ILE 14 A CYS 15 n 15 CYS 15 A HIS 16 n 16 HIS 16 A PRO 17 n 17 PRO 17 A VAL 18 n 18 VAL 18 A PHE 19 n 19 PHE 19 A CYS 20 n 20 CYS 20 A PRO 21 n 21 PRO 21 A ARG 22 n 22 ARG 22 A ARG 23 n 23 ARG 23 A TYR 24 n 24 TYR 24 A LYS 25 n 25 LYS 25 A GLN 26 n 26 GLN 26 A ILE 27 n 27 ILE 27 A GLY 28 n 28 GLY 28 A THR 29 n 29 THR 29 A CYS 30 n 30 CYS 30 A GLY 31 n 31 GLY 31 A LEU 32 n 32 LEU 32 A PRO 33 n 33 PRO 33 A GLY 34 n 34 GLY 34 A THR 35 n 35 THR 35 A LYS 36 n 36 LYS 36 A CYS 37 n 37 CYS 37 A CYS 38 n 38 CYS 38 A LYS 39 n 39 LYS 39 A LYS 40 n 40 LYS 40 A PRO 41 n 41 PRO 41 A author_defined_assembly 1 monomeric 0 0 2970 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N HIS 16 A N HIS 16 A O LYS 36 A O LYS 36 A O LYS 39 A O LYS 39 A N LYS 25 A N LYS 25 1 A A O H VAL LEU 6 9 1.59 1 A A OD2 N ASP THR 4 7 2.13 2 A A O OG1 LEU THR 32 35 2.03 3 A A H O ILE CYS 14 38 1.55 3 A A O H CYS GLY 8 12 1.60 5 A A O H VAL LEU 6 9 1.52 5 A A O H LYS LYS 25 39 1.53 5 A A OD2 H ASP CYS 4 8 1.56 6 A A HD1 O HIS PHE 16 19 1.53 6 A A O H LEU GLY 9 12 1.57 6 A A H O LYS LYS 25 39 1.57 6 A A O HD2 GLY ASP 1 4 1.58 7 A A H OG1 GLY THR 31 35 1.52 8 A A O H LEU GLY 9 12 1.53 8 A A O H VAL LEU 6 9 1.59 9 A A H OG1 GLY THR 31 35 1.47 10 A A O H LYS LYS 25 39 1.58 11 A A H OG1 GLY THR 31 35 1.51 11 A A O H CYS GLY 8 12 1.58 13 A A O H LEU GLY 9 12 1.51 13 A A O H VAL LEU 6 9 1.55 13 A A O H GLY CYS 28 37 1.56 16 A A HD1 O HIS PHE 16 19 1.57 19 A A O H CYS GLY 8 12 1.54 19 A A SG SG CYS CYS 8 30 2.14 20 A A O H LYS LYS 25 39 1.54 20 A A O H CYS GLY 8 12 1.55 1 A ILE 2 -13.45 114.59 1 A VAL 6 -85.46 -72.88 1 A THR 7 -38.06 -29.19 1 A VAL 18 67.08 -76.25 1 A ARG 22 78.54 168.31 1 A GLN 26 -168.50 -59.03 1 A ILE 27 86.33 41.58 1 A CYS 30 -120.13 -56.25 1 A THR 35 -49.94 161.91 2 A ILE 2 2.98 103.26 2 A VAL 18 171.77 -99.35 2 A ARG 22 65.02 172.28 2 A GLN 26 166.99 -68.93 2 A ILE 27 85.66 46.95 2 A CYS 30 -156.23 84.86 3 A ILE 2 -17.10 112.71 3 A SER 11 152.77 44.63 3 A ALA 13 161.64 167.45 3 A VAL 18 77.29 178.99 3 A PHE 19 -42.34 169.36 3 A ARG 22 59.22 166.88 3 A ARG 23 -77.42 20.29 3 A TYR 24 -58.80 -154.58 3 A ILE 27 -173.50 23.88 3 A THR 29 -128.12 -162.05 3 A CYS 30 -140.51 -99.17 3 A LEU 32 -43.76 170.87 4 A ILE 2 -8.00 109.49 4 A ASP 4 178.01 -177.43 4 A VAL 6 -77.59 -71.14 4 A VAL 18 173.55 -100.90 4 A ARG 22 64.31 174.27 4 A ARG 23 -69.84 12.01 4 A GLN 26 171.08 -137.49 4 A ILE 27 162.97 34.70 5 A ILE 2 -10.26 111.57 5 A VAL 6 -89.96 -74.35 5 A THR 7 -36.24 -31.52 5 A LYS 10 -39.41 -29.44 5 A SER 11 153.34 43.21 5 A ALA 13 169.59 170.77 5 A VAL 18 36.94 -148.61 5 A PHE 19 -39.97 162.21 5 A ARG 22 68.12 166.06 5 A ARG 23 -77.07 20.62 5 A TYR 24 -71.31 -165.03 5 A ILE 27 -170.94 21.87 5 A CYS 30 -140.17 -96.73 5 A LEU 32 -46.10 171.22 6 A ILE 2 -55.50 102.05 6 A PRO 5 -74.98 -89.97 6 A VAL 18 173.79 -102.21 6 A ARG 22 75.00 166.68 6 A ARG 23 -68.56 8.96 6 A GLN 26 177.76 -76.63 6 A ILE 27 86.05 55.14 6 A THR 29 -48.93 -174.75 6 A CYS 30 -145.27 -105.61 6 A LEU 32 -47.43 165.54 7 A ILE 2 -28.29 106.49 7 A VAL 6 -75.50 -71.37 7 A THR 7 -39.24 -25.56 7 A VAL 18 174.83 -98.62 7 A ARG 22 74.82 173.67 7 A GLN 26 176.59 -133.18 7 A ILE 27 162.48 43.97 7 A CYS 30 -144.44 -62.02 8 A ILE 2 -38.23 158.24 8 A VAL 6 -78.29 -71.58 8 A VAL 18 39.59 -159.35 8 A PHE 19 -33.86 140.46 8 A ARG 22 66.53 160.10 8 A ARG 23 -78.82 22.48 8 A TYR 24 -65.85 -158.42 8 A ILE 27 -167.73 21.96 8 A THR 29 -129.09 -166.03 8 A CYS 30 172.60 57.19 9 A ILE 2 -33.21 106.56 9 A VAL 6 -79.54 -74.50 9 A THR 7 -38.50 -24.83 9 A SER 11 152.66 45.68 9 A ALA 13 168.93 167.00 9 A VAL 18 173.65 -96.09 9 A PHE 19 -121.26 -149.32 9 A ARG 22 64.56 170.44 9 A ARG 23 -77.20 21.02 9 A TYR 24 -68.43 -165.49 9 A ILE 27 -169.89 21.31 9 A THR 29 -127.89 -167.10 9 A CYS 30 -137.53 -58.62 10 A ILE 2 -32.26 107.13 10 A LYS 10 -38.63 -30.32 10 A SER 11 150.87 42.78 10 A ALA 13 169.74 161.86 10 A VAL 18 171.95 -90.13 10 A PHE 19 -131.09 -159.88 10 A ARG 22 73.54 169.81 10 A TYR 24 -68.58 -164.69 10 A ILE 27 176.20 24.38 10 A THR 29 -118.91 -167.98 10 A CYS 30 -139.80 -107.84 10 A LEU 32 -47.34 161.31 11 A ILE 2 -13.76 115.00 11 A VAL 6 -92.97 -64.96 11 A LYS 10 -39.32 -30.01 11 A SER 11 150.03 44.64 11 A VAL 18 51.79 -155.78 11 A PHE 19 -48.86 -178.78 11 A ARG 22 61.55 174.66 11 A GLN 26 -179.77 -129.24 11 A ILE 27 163.25 53.43 11 A CYS 30 -142.99 -67.16 11 A THR 35 -53.35 170.56 12 A ILE 2 -19.25 111.58 12 A LYS 10 -35.61 -39.27 12 A SER 11 142.90 76.95 12 A VAL 18 39.74 -156.65 12 A PHE 19 -35.44 154.19 12 A ARG 22 70.35 165.60 12 A ARG 23 -76.70 20.15 12 A TYR 24 -69.81 -163.86 12 A ILE 27 -171.49 24.03 12 A THR 29 -129.82 -168.13 12 A CYS 30 -139.59 -95.73 12 A LEU 32 -46.36 170.23 13 A ILE 2 -24.21 134.40 13 A VAL 6 -78.36 -70.12 13 A THR 7 -38.67 -27.87 13 A VAL 18 64.86 -170.99 13 A PHE 19 -45.89 174.57 13 A ARG 22 65.22 160.47 13 A TYR 24 -58.76 -149.63 13 A GLN 26 92.25 -106.61 13 A ILE 27 86.57 43.57 13 A THR 29 -40.69 178.59 13 A THR 35 -51.24 172.98 14 A ILE 2 -23.07 127.42 14 A VAL 18 73.84 -169.71 14 A PHE 19 -49.02 -179.05 14 A ARG 22 62.06 166.44 14 A ARG 23 -77.53 21.01 14 A TYR 24 -61.27 -154.61 14 A ILE 27 -179.18 19.94 14 A LEU 32 -51.57 -165.47 15 A ILE 2 -34.43 137.55 15 A VAL 6 -77.90 -71.99 15 A THR 7 -39.42 -26.78 15 A LYS 10 -39.36 -29.44 15 A SER 11 153.27 44.33 15 A ALA 13 171.21 170.61 15 A VAL 18 169.26 172.87 15 A PHE 19 -41.10 161.41 15 A ARG 22 56.13 171.84 15 A ARG 23 -76.79 21.02 15 A TYR 24 -58.59 -160.51 15 A ILE 27 -167.49 19.70 15 A CYS 30 -106.30 -68.86 15 A THR 35 -51.63 174.80 16 A ILE 2 -23.50 104.17 16 A PRO 5 -74.96 -82.56 16 A THR 7 -37.39 -31.46 16 A SER 11 150.96 -15.73 16 A ALA 13 178.01 -176.63 16 A VAL 18 173.86 -102.58 16 A ARG 22 65.37 168.63 16 A ARG 23 -69.57 10.60 16 A GLN 26 164.92 -76.28 16 A ILE 27 85.89 50.39 16 A THR 29 -45.22 178.64 16 A CYS 30 -131.84 -40.63 16 A PRO 33 -75.04 49.20 16 A THR 35 -52.68 173.62 17 A ILE 2 -29.09 114.16 17 A ASP 4 -174.30 -177.74 17 A VAL 6 -83.24 -72.32 17 A THR 7 -39.42 -28.38 17 A SER 11 157.18 71.65 17 A ALA 13 172.13 174.20 17 A VAL 18 76.23 -169.80 17 A PHE 19 -50.50 -173.87 17 A ARG 22 60.02 166.82 17 A ARG 23 -77.36 20.59 17 A TYR 24 -59.49 -155.45 17 A ILE 27 -171.81 21.58 17 A CYS 30 -133.99 -73.35 18 A ILE 2 47.06 170.12 18 A VAL 18 175.59 -99.35 18 A ARG 22 65.69 170.84 18 A ARG 23 -77.80 21.68 18 A TYR 24 -68.09 -164.48 18 A ILE 27 -169.80 17.59 18 A CYS 30 -84.71 -71.47 18 A THR 35 -50.88 171.21 19 A ILE 2 -7.50 101.30 19 A VAL 6 -94.44 -61.08 19 A ALA 13 176.16 -88.98 19 A VAL 18 76.60 -167.59 19 A PHE 19 -46.53 177.76 19 A ARG 22 67.12 169.76 19 A ARG 23 -68.77 10.92 19 A GLN 26 171.19 -83.44 19 A ILE 27 87.27 55.66 19 A THR 29 -42.71 -175.85 19 A CYS 30 -143.71 -88.71 19 A LEU 32 -43.64 169.63 20 A ILE 2 -23.30 128.36 20 A LYS 10 -39.90 -29.29 20 A SER 11 152.35 44.28 20 A VAL 18 35.92 -150.20 20 A PHE 19 -38.78 159.84 20 A ARG 22 66.46 164.79 20 A ARG 23 -76.69 20.20 20 A TYR 24 -69.93 -164.08 20 A ILE 27 179.93 23.03 20 A THR 29 -122.99 -169.40 20 A CYS 30 -139.47 -42.81 20 A LEU 32 -46.59 177.05 HUMAN BETA-DEFENSIN-2 SOLUTION STRUCTURE OF HUMAN BETA-DEFENSIN-2 1 N N A THR 7 A THR 7 HELX_P A LYS 10 A LYS 10 1 1 4 disulf 1.842 A CYS 8 A SG CYS 8 1_555 A CYS 37 A SG CYS 37 1_555 disulf 2.159 A CYS 15 A SG CYS 15 1_555 A CYS 30 A SG CYS 30 1_555 disulf 2.013 A CYS 20 A SG CYS 20 1_555 A CYS 38 A SG CYS 38 1_555 ANTIBIOTIC DEFENSIN, SOLUTION STRUCTURE, ANTIBIOTIC BD02_HUMAN UNP 1 24 O15263 24 64 1FQQ 1 41 O15263 A 1 1 41 3 anti-parallel anti-parallel A ILE 14 A ILE 14 A HIS 16 A HIS 16 A LYS 36 A LYS 36 A LYS 39 A LYS 39 A LYS 25 A LYS 25 A GLY 28 A GLY 28 1 P 1